Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 25

1.

Advanced Care Directives: Overcoming the Obstacles.

Allen SL, Davis KS, Rousseau PC, Iverson PJ, Mauldin PD, Moran WP.

J Grad Med Educ. 2015 Mar;7(1):91-4. doi: 10.4300/JGME-D-14-00145.1.

2.

Frequency and costs of hospital transfers for ambulatory care-sensitive conditions.

Axon RN, Gebregziabher M, Craig J, Zhang J, Mauldin P, Moran WP.

Am J Manag Care. 2015 Jan;21(1):51-9.

3.

The one-year attributable cost of post-stroke dysphagia.

Bonilha HS, Simpson AN, Ellis C, Mauldin P, Martin-Harris B, Simpson K.

Dysphagia. 2014 Oct;29(5):545-52. doi: 10.1007/s00455-014-9543-8.

4.

Drivers of costs associated with reperfusion therapy in acute stroke: the Interventional Management of Stroke III Trial.

Simpson KN, Simpson AN, Mauldin PD, Hill MD, Yeatts SD, Spilker JA, Foster LD, Khatri P, Martin R, Jauch EC, Kleindorfer D, Palesch YY, Broderick JP; IMS III Investigators..

Stroke. 2014 Jun;45(6):1791-8. doi: 10.1161/STROKEAHA.113.003874.

5.

Effect of endoscopic sphincterotomy for suspected sphincter of Oddi dysfunction on pain-related disability following cholecystectomy: the EPISOD randomized clinical trial.

Cotton PB, Durkalski V, Romagnuolo J, Pauls Q, Fogel E, Tarnasky P, Aliperti G, Freeman M, Kozarek R, Jamidar P, Wilcox M, Serrano J, Brawman-Mintzer O, Elta G, Mauldin P, Thornhill A, Hawes R, Wood-Williams A, Orrell K, Drossman D, Robuck P.

JAMA. 2014 May;311(20):2101-9. doi: 10.1001/jama.2014.5220.

6.

Can patient and pain characteristics predict manometric sphincter of Oddi dysfunction in patients with clinically suspected sphincter of Oddi dysfunction?

Romagnuolo J, Cotton PB, Durkalski V, Pauls Q, Brawman-Mintzer O, Drossman DA, Mauldin P, Orrell K, Williams AW, Fogel EL, Tarnasky PR, Aliperti G, Freeman ML, Kozarek RA, Jamidar PA, Wilcox CM, Serrano J, Elta GH.

Gastrointest Endosc. 2014 May;79(5):765-72. doi: 10.1016/j.gie.2013.11.037.

7.

Psychosocial characteristics and pain burden of patients with suspected sphincter of Oddi dysfunction in the EPISOD multicenter trial.

Brawman-Mintzer O, Durkalski V, Wu Q, Romagnuolo J, Fogel E, Tarnasky P, Aliperti G, Freeman M, Kozarek R, Jamidar P, Wilcox M, Elta G, Orrell K, Wood A, Mauldin P, Serrano J, Drossman D, Robuck P, Cotton P.

Am J Gastroenterol. 2014 Mar;109(3):436-42. doi: 10.1038/ajg.2013.467.

8.

Comparison of Hospitalwide and Custom Antibiograms for Clinical Isolates of Pseudomonas aeruginosa.

Bosso JA, Sieg A, Mauldin PD.

Hosp Pharm. 2013 Apr;48(4):295-301. doi: 10.1310/hpj4804-295.test.

9.

Fitting parametric random effects models in very large data sets with application to VHA national data.

Gebregziabher M, Egede L, Gilbert GE, Hunt K, Nietert PJ, Mauldin P.

BMC Med Res Methodol. 2012 Oct 24;12:163. doi: 10.1186/1471-2288-12-163.

10.

Differential impact of longitudinal medication non-adherence on mortality by race/ethnicity among veterans with diabetes.

Egede LE, Lynch CP, Gebregziabher M, Hunt KJ, Echols C, Gilbert GE, Mauldin PD.

J Gen Intern Med. 2013 Feb;28(2):208-15. doi: 10.1007/s11606-012-2200-8.

11.

Medication nonadherence in diabetes: longitudinal effects on costs and potential cost savings from improvement.

Egede LE, Gebregziabher M, Dismuke CE, Lynch CP, Axon RN, Zhao Y, Mauldin PD.

Diabetes Care. 2012 Dec;35(12):2533-9. doi: 10.2337/dc12-0572.

12.

The one-year attributable cost of poststroke aphasia.

Ellis C, Simpson AN, Bonilha H, Mauldin PD, Simpson KN.

Stroke. 2012 May;43(5):1429-31. doi: 10.1161/STROKEAHA.111.647339.

13.

Relationship between vancomycin trough concentrations and nephrotoxicity: a prospective multicenter trial.

Bosso JA, Nappi J, Rudisill C, Wellein M, Bookstaver PB, Swindler J, Mauldin PD.

Antimicrob Agents Chemother. 2011 Dec;55(12):5475-9. doi: 10.1128/AAC.00168-11.

14.

Regional, geographic, and racial/ethnic variation in glycemic control in a national sample of veterans with diabetes.

Egede LE, Gebregziabher M, Hunt KJ, Axon RN, Echols C, Gilbert GE, Mauldin PD.

Diabetes Care. 2011 Apr;34(4):938-43. doi: 10.2337/dc10-1504.

15.

Challenges in planning and initiating a randomized clinical study of sphincter of Oddi dysfunction.

Cotton PB, Durkalski V, Orrell KB, Brawman-Mintzer O, Drossman DA, Wilcox CM, Mauldin PD, Elta GH, Tarnasky PR, Fogel EL, Jagganath SB, Kozarek RA, Freeman ML, Romagnuolo J, Robuck PR.

Gastrointest Endosc. 2010 Nov;72(5):986-91. doi: 10.1016/j.gie.2010.08.022.

16.

Measuring episodic abdominal pain and disability in suspected sphincter of Oddi dysfunction.

Durkalski V, Stewart W, MacDougall P, Mauldin P, Romagnuolo J, Brawman-Minzter O, Cotton P.

World J Gastroenterol. 2010 Sep 21;16(35):4416-21.

17.

Rationale and design: telephone-delivered behavioral skills interventions for Blacks with Type 2 diabetes.

Egede LE, Strom JL, Durkalski VL, Mauldin PD, Moran WP.

Trials. 2010 Mar 29;11:35. doi: 10.1186/1745-6215-11-35.

18.

Attributable hospital cost and length of stay associated with health care-associated infections caused by antibiotic-resistant gram-negative bacteria.

Mauldin PD, Salgado CD, Hansen IS, Durup DT, Bosso JA.

Antimicrob Agents Chemother. 2010 Jan;54(1):109-15. doi: 10.1128/AAC.01041-09.

19.

Rationale and design: telepsychology service delivery for depressed elderly veterans.

Egede LE, Frueh CB, Richardson LK, Acierno R, Mauldin PD, Knapp RG, Lejuez C.

Trials. 2009 Apr 20;10:22. doi: 10.1186/1745-6215-10-22.

20.

Optimal frequency for measuring health care resource utilization in Parkinson's disease using participant recall: the FS-TOO resource utilization substudy.

Mauldin PD, Guimaraes P, Albin RL, Ray Dorsey E, Bainbridge JL, Siderowf A; NINDS NET-PD Investigators..

Clin Ther. 2008 Aug;30(8):1553-7. doi: 10.1016/j.clinthera.2008.08.001.

Items per page

Supplemental Content

Loading ...
Support Center